Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors

Marianna Storto, Loredana Capobianco, Giuseppe Battaglia, Gemma Molinaro, Roberto Gradini, Barbara Riozzi, Alessandra Di Mambro, Kathryn J. Mitchell, Valeria Bruno, Maria P. Vairetti, Guy A. Rutter, Ferdinando Nicoletti

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Recent evidence suggests that metabotropic glutamate (mGlu) receptors are involved in the regulation of hormone secretion in the endocrine pancreas. We report here that endogenous activation of mGlu5 receptors is required for an optimal insulin response to glucose both in clonal β-cells and in mice. In clonal β-cells, mGlu5 receptors were expressed at the cell surface and were also found in purified insulin-containing granules. These cells did not respond to a battery of mGlu5 receptor agonists that act extracellularly, but instead responded to a cell-permeant analog of glutamate with an increase in [Ca 2+]i and insulin secretion. Both effects were largely attenuated by the mGlu5 receptor antagonist, 2-methyl-6-(phenylethynyl)-pyridine (MPEP). MPEP and its structural analog, (E)-2-methyl-6-styryl-pyridine (SIB-1893), reduced the increase in [Ca2+]i and insulin secretion induced by glucose in clonal β-cells, whereas a mGlu1 receptor antagonist was inactive. mGlu5 knockout mice showed a defective insulin response at all times after a glucose pulse (1.5 g/kg, i.p.), whereas wild-type mice treated with MPEP (10 mg/kg, i.p.) showed a selective impairment in the late phase of insulin secretion in response to glucose challenge. Mice injected with MPEP or lacking mGlu5 receptors also showed a blunted glucagon response to an insulin challenge. We conclude that insulin secretion is under the control of mGlu5 receptors both in clonal β-cells and in vivo. Drugs that modulate the function of mGlu5 receptors might affect glucose homeostasis by altering the secretion of pancreatic hormones.

Original languageEnglish (US)
Pages (from-to)1234-1241
Number of pages8
JournalMolecular Pharmacology
Volume69
Issue number4
DOIs
StatePublished - Apr 1 2006

Fingerprint

Metabotropic Glutamate Receptors
Insulin
Glucose
Pancreatic Hormones
Glucagon
Islets of Langerhans
Knockout Mice
Glutamic Acid
Homeostasis
Hormones
pyridine

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Storto, M., Capobianco, L., Battaglia, G., Molinaro, G., Gradini, R., Riozzi, B., ... Nicoletti, F. (2006). Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors. Molecular Pharmacology, 69(4), 1234-1241. https://doi.org/10.1124/mol.105.018390

Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors. / Storto, Marianna; Capobianco, Loredana; Battaglia, Giuseppe; Molinaro, Gemma; Gradini, Roberto; Riozzi, Barbara; Di Mambro, Alessandra; Mitchell, Kathryn J.; Bruno, Valeria; Vairetti, Maria P.; Rutter, Guy A.; Nicoletti, Ferdinando.

In: Molecular Pharmacology, Vol. 69, No. 4, 01.04.2006, p. 1234-1241.

Research output: Contribution to journalArticle

Storto, M, Capobianco, L, Battaglia, G, Molinaro, G, Gradini, R, Riozzi, B, Di Mambro, A, Mitchell, KJ, Bruno, V, Vairetti, MP, Rutter, GA & Nicoletti, F 2006, 'Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors', Molecular Pharmacology, vol. 69, no. 4, pp. 1234-1241. https://doi.org/10.1124/mol.105.018390
Storto, Marianna ; Capobianco, Loredana ; Battaglia, Giuseppe ; Molinaro, Gemma ; Gradini, Roberto ; Riozzi, Barbara ; Di Mambro, Alessandra ; Mitchell, Kathryn J. ; Bruno, Valeria ; Vairetti, Maria P. ; Rutter, Guy A. ; Nicoletti, Ferdinando. / Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors. In: Molecular Pharmacology. 2006 ; Vol. 69, No. 4. pp. 1234-1241.
@article{61dfa74ca970411cb6235e94647a4b61,
title = "Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors",
abstract = "Recent evidence suggests that metabotropic glutamate (mGlu) receptors are involved in the regulation of hormone secretion in the endocrine pancreas. We report here that endogenous activation of mGlu5 receptors is required for an optimal insulin response to glucose both in clonal β-cells and in mice. In clonal β-cells, mGlu5 receptors were expressed at the cell surface and were also found in purified insulin-containing granules. These cells did not respond to a battery of mGlu5 receptor agonists that act extracellularly, but instead responded to a cell-permeant analog of glutamate with an increase in [Ca 2+]i and insulin secretion. Both effects were largely attenuated by the mGlu5 receptor antagonist, 2-methyl-6-(phenylethynyl)-pyridine (MPEP). MPEP and its structural analog, (E)-2-methyl-6-styryl-pyridine (SIB-1893), reduced the increase in [Ca2+]i and insulin secretion induced by glucose in clonal β-cells, whereas a mGlu1 receptor antagonist was inactive. mGlu5 knockout mice showed a defective insulin response at all times after a glucose pulse (1.5 g/kg, i.p.), whereas wild-type mice treated with MPEP (10 mg/kg, i.p.) showed a selective impairment in the late phase of insulin secretion in response to glucose challenge. Mice injected with MPEP or lacking mGlu5 receptors also showed a blunted glucagon response to an insulin challenge. We conclude that insulin secretion is under the control of mGlu5 receptors both in clonal β-cells and in vivo. Drugs that modulate the function of mGlu5 receptors might affect glucose homeostasis by altering the secretion of pancreatic hormones.",
author = "Marianna Storto and Loredana Capobianco and Giuseppe Battaglia and Gemma Molinaro and Roberto Gradini and Barbara Riozzi and {Di Mambro}, Alessandra and Mitchell, {Kathryn J.} and Valeria Bruno and Vairetti, {Maria P.} and Rutter, {Guy A.} and Ferdinando Nicoletti",
year = "2006",
month = "4",
day = "1",
doi = "10.1124/mol.105.018390",
language = "English (US)",
volume = "69",
pages = "1234--1241",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

TY - JOUR

T1 - Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors

AU - Storto, Marianna

AU - Capobianco, Loredana

AU - Battaglia, Giuseppe

AU - Molinaro, Gemma

AU - Gradini, Roberto

AU - Riozzi, Barbara

AU - Di Mambro, Alessandra

AU - Mitchell, Kathryn J.

AU - Bruno, Valeria

AU - Vairetti, Maria P.

AU - Rutter, Guy A.

AU - Nicoletti, Ferdinando

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Recent evidence suggests that metabotropic glutamate (mGlu) receptors are involved in the regulation of hormone secretion in the endocrine pancreas. We report here that endogenous activation of mGlu5 receptors is required for an optimal insulin response to glucose both in clonal β-cells and in mice. In clonal β-cells, mGlu5 receptors were expressed at the cell surface and were also found in purified insulin-containing granules. These cells did not respond to a battery of mGlu5 receptor agonists that act extracellularly, but instead responded to a cell-permeant analog of glutamate with an increase in [Ca 2+]i and insulin secretion. Both effects were largely attenuated by the mGlu5 receptor antagonist, 2-methyl-6-(phenylethynyl)-pyridine (MPEP). MPEP and its structural analog, (E)-2-methyl-6-styryl-pyridine (SIB-1893), reduced the increase in [Ca2+]i and insulin secretion induced by glucose in clonal β-cells, whereas a mGlu1 receptor antagonist was inactive. mGlu5 knockout mice showed a defective insulin response at all times after a glucose pulse (1.5 g/kg, i.p.), whereas wild-type mice treated with MPEP (10 mg/kg, i.p.) showed a selective impairment in the late phase of insulin secretion in response to glucose challenge. Mice injected with MPEP or lacking mGlu5 receptors also showed a blunted glucagon response to an insulin challenge. We conclude that insulin secretion is under the control of mGlu5 receptors both in clonal β-cells and in vivo. Drugs that modulate the function of mGlu5 receptors might affect glucose homeostasis by altering the secretion of pancreatic hormones.

AB - Recent evidence suggests that metabotropic glutamate (mGlu) receptors are involved in the regulation of hormone secretion in the endocrine pancreas. We report here that endogenous activation of mGlu5 receptors is required for an optimal insulin response to glucose both in clonal β-cells and in mice. In clonal β-cells, mGlu5 receptors were expressed at the cell surface and were also found in purified insulin-containing granules. These cells did not respond to a battery of mGlu5 receptor agonists that act extracellularly, but instead responded to a cell-permeant analog of glutamate with an increase in [Ca 2+]i and insulin secretion. Both effects were largely attenuated by the mGlu5 receptor antagonist, 2-methyl-6-(phenylethynyl)-pyridine (MPEP). MPEP and its structural analog, (E)-2-methyl-6-styryl-pyridine (SIB-1893), reduced the increase in [Ca2+]i and insulin secretion induced by glucose in clonal β-cells, whereas a mGlu1 receptor antagonist was inactive. mGlu5 knockout mice showed a defective insulin response at all times after a glucose pulse (1.5 g/kg, i.p.), whereas wild-type mice treated with MPEP (10 mg/kg, i.p.) showed a selective impairment in the late phase of insulin secretion in response to glucose challenge. Mice injected with MPEP or lacking mGlu5 receptors also showed a blunted glucagon response to an insulin challenge. We conclude that insulin secretion is under the control of mGlu5 receptors both in clonal β-cells and in vivo. Drugs that modulate the function of mGlu5 receptors might affect glucose homeostasis by altering the secretion of pancreatic hormones.

UR - http://www.scopus.com/inward/record.url?scp=33645109953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645109953&partnerID=8YFLogxK

U2 - 10.1124/mol.105.018390

DO - 10.1124/mol.105.018390

M3 - Article

C2 - 16424079

AN - SCOPUS:33645109953

VL - 69

SP - 1234

EP - 1241

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 4

ER -